Advocacy intelligence hub — real-time data for patient organizations
Takeda — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
ELAPRASE
Takeda Pharmaceuticals America, Inc.
ELAPRASE
(IDURSULFASE)Orphan drugstandardTakeda Pharmaceuticals America, Inc.
Paul Orchard, MD, MD
University of Minnesota Medical Center
📍 MINNEAPOLIS, MN
Tippi C MacKenzie, MD
University of California, San Francisco
📍 San Francisco, California
Joanne Kurtzberg, MD, M.D
Duke University
📍 DURHAM, NC
Dong-Kyu Jin
Samsung medical center, Seoul, Republic of Korea
Suhag Parikh, MD, M.D
Duke Pediatric Blood and Marrow Transplant
📍 CHICAGO, IL
Ashley Schneider
University of Minnesota